[1]
Karande, S.P., Munshi, R.P. and Kumbhar, D.A. 2017. A double blind, randomized, placebo controlled, phase IV, proof-of-concept, comparative study to evaluate the efficacy and safety of Swasawin asthaloc tablets when given as add-on therapy in patients suffering from mild to moderate persistent bronchial asthma. International Journal of Research in Medical Sciences. 5, 11 (Oct. 2017), 4929–4936. DOI:https://doi.org/10.18203/2320-6012.ijrms20174947.